Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06110897 · ClinicalTrials.gov registry record · NA

RESISTance Exercise for Depression Trial

A NA study of Major Depressive Disorder, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT06110897 is a NA study of Major Depressive Disorder that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 200 participants, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (47% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06110897, a NA study of Major Depressive Disorder, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

Depression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 adults.

Conditions Studied

Interventions

  • BEHAVIORAL High Dose Resistance Exercise Training
  • BEHAVIORAL Low Dose Resistance Exercise Training Group

Study Locations (2)

Iowa

  • Iowa State University - Ames

Wisconsin

  • University of Wisconsin - Madison - Madison

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-01-01
Est. Completion 2028-05-31
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT06110897

The ClinicalTrials.gov registry entry for NCT06110897 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (47% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which High Dose Resistance Exercise Training is the first listed.

NCT06110897 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Iowa, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06110897 about?

NCT06110897 is a clinical study titled "RESISTance Exercise for Depression Trial". Depression is a leading cause of disability worldwide and current treatments are ineffective for many people. This trial will investigate the efficacy of a 16-week high vs low dose resistance exercise training program for the treatment of Major Depressive Disorder (MDD) in 200 adults.

What is the current status of trial NCT06110897?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-01-01. Estimated completion is 2028-05-31.

What conditions does trial NCT06110897 study?

This clinical trial studies the following conditions: Major Depressive Disorder.

What interventions are being tested in trial NCT06110897?

The interventions under investigation include: High Dose Resistance Exercise Training (BEHAVIORAL), Low Dose Resistance Exercise Training Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06110897?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06110897 being conducted?

This trial has 2 study locations across Iowa, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.